Sign up
Pharma Capital

Medlab Clinical chief updates on progress with NanaBis and NRG Biotic

Medlab Clinical Ltd (ASX:MDC) managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference & Trade Exhibition (APP2019).

Hall updates on the progress of clinical trials for NRGBiotic™, a nutraceutical already available in pharmacies.

He also discusses a recent heads of agreement (HoA) reached with Canadian pharmaceutical company Pharmascience Inc. for the further development and global distribution of NanaBis™, which is also progressing through clinical trials.

 

View full MDC profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.